Our Unique Product Portfolio

Our unique product portfolio is second to none! It will help you to achieve the treatment results you desire for face and body.

Product quality and safety are of highest importance in our research and development activities. Our products are solely produced in world-class manufacturing facilities in Germany, Switzerland and the U.S. We are proud our products regularly get awarded for their outstanding results and reliability. Get to know our unique solutions!

The Merz Aesthetics Product Portfolio


BELOTERO® is the high-quality range of hyaluronic acid dermal llers with patented CPM® (Cohesive Polydensi ed Matrix) technology that integrates smoothly into tissues. It is the ideal solution for smoothing wrinkles, restoring facial volume, and rehydrating the skin.


Botulinum Toxin is a prescription product. If you have any questions, please contact your doctor or visit us at Merz Institute of Advanced Aesthetics.



CELLFINA® is the minimally invasive cellulite treatment intended for long-term improvement in the appearance of cellulite in the buttocks and thigh areas of adult females, with proven results that last for years.



Neocutis® is a range of cosmeceuticals that uses proprietary and innovative technologies for skin rejuvenation with proven clinical efficacy.



RADIESSE® is a unique calcium hydroxylapatite-based dermal filler cleared by the FDA, designed for the reduction of moderate to deep lines, lifting and contouring with collagen-based volume enhancement, and for long-term improvement in skin quality.



ULTHERAPY® harnesses the power of ultrasound. It is the only FDA-cleared non-invasive lift for the neck, chin, and brow, and can also improve lines and wrinkles on the décolleté. Its unique visualization capability allows to see where the treatment is delivered for each unique patient.


Unique Portfolio for Unique Results

We have carefully compiled the individual solutions in our portfolio and have constantly added new technologies to our offer. The complementary nature of these solutions helps achieving state-of-the-art results. Long-term treatment planning and a multimodal approach will allow treating each patient with one or more products to meet their individual needs!